000 | 01265 a2200373 4500 | ||
---|---|---|---|
005 | 20250516121521.0 | ||
264 | 0 | _c20130806 | |
008 | 201308s 0 0 eng d | ||
022 | _a1423-0313 | ||
024 | 7 |
_a10.1159/000343243 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBauer, M | |
245 | 0 | 0 |
_aPharmacokinetics of single ascending doses of the P-glycoprotein inhibitor tariquidar in healthy subjects. _h[electronic resource] |
260 |
_bPharmacology _c2013 |
||
300 |
_a12-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
650 | 0 | 4 | _aAdministration, Intravenous |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aQuinolines _xadverse effects |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aZeitlinger, M | |
700 | 1 | _aTodorut, D | |
700 | 1 | _aBöhmdorfer, M | |
700 | 1 | _aMüller, M | |
700 | 1 | _aLanger, O | |
700 | 1 | _aJäger, W | |
773 | 0 |
_tPharmacology _gvol. 91 _gno. 1-2 _gp. 12-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000343243 _zAvailable from publisher's website |
999 |
_c22259141 _d22259141 |